Pilotstudy to characterise prostate tissue using dynamic contrast enhanced (DCE-) MRI in patients with localised prostate cancer.
Completed
- Conditions
- 1003859710018188blood perfusionprostate cancer
- Registration Number
- NL-OMON31676
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Patients who will receive a prostatectomy as treatment for a locallised prostate cancer
Exclusion Criteria
No contraindications for a 3.0 T MRI
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The interpretation of the DCE-MRI will be in terms of vasculature, microvessel<br /><br>density and the amount of vessel leakage.<br /><br><br /><br>The first question is whether this interpretation has it's basis in histology.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The second question is whtether these histologic characterisations can be<br /><br>correlated with the presence of tumour and it's oxygenation.</p><br>